The Marketer’s Anatomy is a deep dive into the minds of veteran life science marketing leaders, dissecting their hard-earned lessons, industry experience and tried-and-tested advice. Hosted by Xtalks B2B Life Science Marketing Insights, each interview closely examines the practical tips and career wisdom needed to successfully navigate the market and grow pharma and biotech brands today.
Life science marketing is changing quickly, but the challenge is still familiar: how do you earn attention, build trust and communicate clearly in a market where the stakes are high and the audience is highly specialized? At Xtalks, that question comes up often in our work with marketing teams across the industry. The Marketer’s Anatomy was created to explore it through conversations with experienced leaders in pharma, biotech and healthcare marketing.
In this episode, Xtalks’ Director of Demand Generation Solutions, Insiya Meherally, interviews Jon Carnero, Omnichannel Marketing Lead at GSK, about balancing compliance with creativity, maintaining a human touch in an AI-driven world and the critical skills marketers must focus on developing next.
Omnichannel Marketing Lead
GSK
From Sesame Street to the front lines of global pharmaceutical launches, Jon Carnero’s career journey is anything but conventional.
He started at Dentsu in Tokyo before moving into roles at agencies like Digitas and RAPP, eventually overseeing a substantial P&L for clients like Pfizer, Lilly and Gilead. Along the way, he’s done everything from serving on Google’s Health Marketing Advisory Board to launching an integrated campaign for Perrier featuring Andy Warhol. Today, he’s an Omnichannel Marketing Lead at GSK, where he’s worked on high-profile launches like Arexvy.
When I sat down with Jon, he described his career as a mix of a “major and a minor.” Healthcare is his primary focus, but he pulls constantly from his “minor” in consumer marketing and customer experience (CX). For Jon, the goal isn’t just to follow the standard pharma playbook; it’s to use those outside perspectives to change how the industry connects with people.
“I’ve never really stayed in one area long enough to stop borrowing from the other ones,” Jon says, “and I truly believe that’s an advantage.” This outsider perspective is what eventually drew him to the brand side. He wanted to do more than execute a creative brief; he wanted to be accountable for the actual results. For Jon, the core of the work is “being at the intersection of data and creating a narrative that really changes behavior positively,” whether that involves a doctor, a patient or a caregiver.
How Do You Balance Compliance With Creative Storytelling?
In a field as heavily regulated as life sciences, it is easy to view the legal and medical review process as a hurdle. Jon sees it as a sharpening stone. He argues that the tension between compliance and creativity is actually a misunderstanding of how great work gets made.
“Compliance really tells you what your lane is and then the creativity is how you drive in it,” he explains. Rather than viewing rules as a cage, he believes the best brands treat regulatory review like a tough editor who makes a writer better, rather than a filter that “takes all the meat off the bone.”
“Where I’ve seen the real failures happen is when compliance and creativity are siloed,” Jon observes. “The MLR process then becomes a wall instead of a dialogue.” To him, the key is getting medical and regulatory partners in the room early.
He also explains how anchoring a story in a human truth often provides more room to move than most people would think. “If a pulmonologist is recommending an asthma medicine, they may not always be thinking about the clinical endpoints,” Jon notes. “They could be wondering if that patient can get up a flight of stairs without stopping.”
How Do You Maintain a ‘Human’ Feel in an AI-Driven World?
Jon sees the shift toward AI as a chance to focus on what people actually need from healthcare communications. He believes that in a fast-moving therapeutic area, professionals and patients don’t need more noise. “What they don’t need is more messaging,” he clarifies. “What they do need is communications that feel authentic and relevant to where they are at that moment.”
For Jon, the real opportunity is using technology to bridge the gap between a brand’s message and a person’s real-life situation. “The shift is from message delivery to experience design,” he says.
He emphasizes that being human in marketing simply means understanding that a cardiologist has different needs than a primary care physician, or that a skeptical patient needs a different approach than a caregiver. The danger lies in using technology to just move faster without a more strategic plan. “If you’re just scaling a generic message faster, you’re just producing ‘generic’ at scale and that’s actually worse,” Jon says.
What Is One Thing AI Will Never Be Able to Replace?
Despite the power of automation, Jon is firm that trust is “structurally” impossible for AI to replace. “To earn trust, you have to build that in the room,” he says. AI can find an audience, but “it can’t sit across from an HCP at a medical congress and make that HCP feel seen.”
Trust takes years to build and requires a human presence that an AI model can’t replicate.
He points out that the biggest moves in this industry, like winning over a key opinion leader (KOL), happen because “one human makes a judgment call that another human is credible.”
“AI also can’t read the room,” Jon continues. “If you’re in a patient advocacy group and they’re skeptical, AI won’t be able to adjust to that skepticism in real time.” He feels that this kind of fundamental trust takes years to build and requires a human presence that a model can’t replicate.
What Critical Skill Must Life Science Marketers Develop Next?
Looking toward the future, Jon believes the most critical skill for any marketer isn’t technical; it’s what he calls “horse sense, street smarts and just good judgment.” He states that while AI is excellent at optimizing a subject line or a send time, it cannot tell whether a user is asking the right questions.
“Critical thinking is knowing when to override that model,” Jon explains. He worries that marketers are often measuring the wrong things, like engagement instead of actual behavior change. “Does this metric really proxy well for what we’re caring about?” he asks.
Ultimately, Jon advises marketers to look past what can be taught by a prompt. While he says to “become fluent in your AI tools 100%,” he stresses that it takes human experience and natural curiosity to recognize when data is “technically correct yet strategically wrong.” For Jon, true value comes from understanding the audience deeply enough to know when to override the model. “Really develop strong opinions about what ‘good’ looks like because you are the judgment layer and that’s where your value lives,” he concludes.
That is exactly what The Marketer’s Anatomy is here to explore: what good judgment looks like in life science marketing today for teams trying to reach pharma, biotech and healthcare audiences. Through this series, Xtalks will continue speaking with marketers who have practical, hard-earned perspectives on where the industry is heading.
Know a standout life science marketing leader with great advice to share?
Get in touch with us below to nominate them for a future interview.
Let's Talk Strategy
Join or login to leave a comment
JOIN LOGIN